Form 4: DSS, Inc. Increases Stake in Impact Biomedical Inc.

DSS, Inc. reports acquiring 1,000 shares of Impact Biomedical Inc. common stock at $2.33 per share.

Summary

• On September 18, 2024, DSS, Inc. acquired 1,000 shares of Impact Biomedical Inc. (IBO) common stock.
• The purchase price was $2.33 per share.
• Following the transaction, DSS, Inc. indirectly owns a total of 58,800 shares through Sentinel Brokers Company, Inc., a majority-owned subsidiary.
• DSS, Inc. also indirectly owns 1,345,482 shares through DSS BioHealth Security, Inc., 166,600 shares through DSS Securities, Inc., and 166,600 shares through DSS BlockChain Security, Inc., all of which are wholly-owned subsidiaries.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard SEC filing reporting a transaction. The increase in shares could be seen as slightly positive, but without further context, it's difficult to assess the overall impact.

Positives

• DSS, Inc.'s increased investment in Impact Biomedical Inc. could signal confidence in the latter's prospects.

Risks

• The document does not provide any information about the financial health or future prospects of either DSS, Inc. or Impact Biomedical Inc.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell the company's securities. This filing indicates a change in DSS, Inc.'s ownership stake in Impact Biomedical Inc.

Stakeholder Impact

• Shareholders of Impact Biomedical Inc. may react to the news of DSS, Inc.'s increased stake.

Key Dates